Arvinas, Inc. ( ARVN) - Key Metrics
ARVN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.15 | -$1.04 | -$0.47 | -$0.47 |
| 2025Q3 | $0.57 | -$0.48 | -$0.81 | -$0.81 |
| 2025Q2 | $0.31 | -$0.84 | -$1.31 | -$1.33 |
| 2025Q1 | $2.60 | $1.14 | -$1.23 | -$1.23 |
ARVN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.86 |
| 2025Q3 | ? | -4.42 |
| 2025Q2 | ? | -2.19 |
| 2025Q1 | ? | 1.53 |
ARVN
Price: $7.38
52 week price:
Earnings Per Share: -3.18 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 476209
Market Capitalization: 496.8 million